A Phase 1, First-in-Human Study of CTIM-76, a Claudin-6 (CLDN6)-Directed Bispecific Antibody, in Patients with Recurrent Ovarian Cancer and Other Advanced Solid Tumors

Roisin E. O’Cearbhaill, Minal Barve, Christopher J. Darus, Nashat Gabrail, Paul Johannet, Jade Loh, MaryBeth LeRose, Angela Jain, Martin Gutierrez, Michael J. Birrer

American Society of Clinical Oncology I Annual Meeting I Abstract TPS2685 I May 30-June 3, 2025

Kelly Byrnes-Blake, Edward Calamai, Stanley Roberts, and Eric Butz

Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting I Abstract 1288 I November 7-11, 2024

Hayley Roth, Samantha Brady, Ileine Sanchez, Breanna Tyrell, Guangming Liu, Holden Ohl, Nicholas Molino, Eric Butz, Ed Calamai, Stanley Roberts, Kelly Byrnes-Blake, Kyle Doolan, Ross Chambers, and Joseph Rucker

Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting I Abstract 1183 I November 2-5, 2023